Home
|
News
|
Events
|
Contact Us
|
English
|
繁體中文
|
日本語
About Us
Product & Service
Facilities
Quality & Compliance
For Investors
Career
|
Company
|
Milestone
|
People
|
Mission Statement
|
Organization
|
Contact Us
|
|
Active Pharmaceutical Ingredients
|
Contract Development and Manufacturing Organization (CDMO)
|
Antibody Drug Conjugates (ADCs)
|
Injectable Manufacturing Services
|
|
Kilo Lab
|
Commercial Production
|
High Potency API (HPAPI)
|
Analytical instrument
|
|
DMFs & CEPs
|
Inspection
|
Certificates
|
SHE Policy
|
Intellectual Property
|
Award
|
|
Financials
|
Corporate Governance
|
Shareholder Services
|
CSR
|
FAQ
Latest Events
Latest News
Product & Service
BioTaiwan 2022, Taipei
July. 28-31, 2022
Booth no. R321
CPhI Worldwide, Frankfurt, Germany
Nov. 01-03, 2022
Formosa Injectable plant passed GMP/GDP inspection by TFDA.(Jun. 15, 2022)
2022-06-21
Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery
2022-05-13
Formosa Laboratories, Formosa Pharmaceuticals and HCmed Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs
2022-03-07
Passed GDP inspection by TFDA for medicinal products. (Sep. 27th, 2021)
2021-11-11
Passed GMP inspection by TFDA for packaging and labeling of medicinal products. (Sep. 15th, 2021)
2021-11-11
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
Injectable Manufacturing Services
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝